Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Oussama M Wazni , Allan L Klein Added: 3 years ago
Atrial fibrillation (AF) is the most commonly sustained arrhythmia with a prevalence of 0.4% in the general population1-4 affecting 2.3 million people in the US.5 The prevalence increases with age being <1% in persons younger than 60 years of age to >8% in those older than 80 years.1,5-8 The incidence ranges from 0.2% per year for men 30 to 39 years of age to 2.3% per year in men 80 to 89… View more
Author(s): David Conen Added: 3 years ago
Patients with AF have an increased risk of dementia and clinical stroke. Dr David Conen (Mcmaster University, Hamilton, ON, CA) discusses the results of this large cohort study aimed at investigating if dementia can be mitigated using novel oral anticoagulation (OAC). He also sheds light on what further studies are needed in follow-up to these results. Questions: 1. Why did you conduct this… View more
Job title: Physicians
Author(s): Paul A Friedman , Stephen C Hammill Added: 3 years ago
Atrial fibrillation (AF) is a rhythm disturbance of the atria that results in irregular, chaotic, ventricular waveforms, varying from bradyarrhythmia to tachyarrhythmia. Essentially, all forms of AF therapy can be divided into two categories - restoration and maintenance of normal sinus rhythm, or control of the ventricular rate while permitting on-going fibrillation of the atria. Although… View more
Job title: Head Of Section - Heart Rhythm Services
Personal History A native of Logan Utah , Dr Thomas Jared Bunch is an Electrophysiologist focused on heart rhythms.2 He is an avid sports fan particularly devoted to his alma mater. He enjoys long distance running, endurance training, community work with youth organizations and mentoring young clinical investigators.5 Academic History Dr Bunch got his BA from Utah State University… View more
Author(s): Charles H Hennekens , Danielle Hollar , Arthur S Agatston Added: 3 years ago
While the proximate cause of virtually all acute cardiovascular disease (CVD) syndromes is thrombosis, the principal underlying cause is atherosclerosis. With respect to aspirin, in basic research this drug irrepressibly acetylates the active site of cyclo-oxygenase in platelets which inhibits thromboxane A2, a powerful promoter of aggregation. In randomized trials of secondary prevention and… View more
Author(s): Mandeep Mehra , Christian Inchaustegui Added: 5 months ago
In 2023, we are excited to partner with @CardioNerds, a dynamic team dedicated to democratizing cardiovascular education. Experience a fresh perspective on the new data through an interview series featuring principal investigators and ambassadors from the CardioNerds family.These interviews are supported by an educational grant from Novo Nordisk Inc. This content is not intended for UK HCPs. View more